Rivus Pharmaceuticals Funding: $167M Raised, Series B (2022)
Rivus Pharmaceuticals is based in Charlottesville. It has raised $167M in total funding. Latest round: Series B.
Rivus Pharmaceuticals funding overview
Rivus Pharmaceuticals is based in Charlottesville. Rivus Pharmaceuticals has raised $167M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2022. The round record for Rivus Pharmaceuticals runs through 2022; nothing later has been disclosed. Investors on record include RA Capital Management, Longitude Capital, Medicxi, Rx Capital, Bain Capital Life Sciences, BB Biotech. 6 distinct backers are named across the disclosed rounds.
Rivus Pharmaceuticals at a glance
Total raised
$167M
Latest round
Series B
Latest round date
September 2022
Headquarters
Charlottesville
Notable investors
RA Capital Management, Longitude Capital, Medicxi, Rx Capital, Bain Capital Life Sciences, BB Biotech
Frequently asked about Rivus Pharmaceuticals funding
How much has Rivus Pharmaceuticals raised?
Rivus Pharmaceuticals has raised $167M in total disclosed funding across the rounds on record.
Who has invested in Rivus Pharmaceuticals?
RA Capital Management, Longitude Capital, Medicxi, Rx Capital, Bain Capital Life Sciences, BB Biotech are named among the investors backing Rivus Pharmaceuticals.
What was the latest Rivus Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in September 2022.
Where is Rivus Pharmaceuticals based?
Rivus Pharmaceuticals is based in Charlottesville.
When did Rivus Pharmaceuticals last raise?
The last disclosed Rivus Pharmaceuticals round closed in September 2022 at Series B.
We update the Rivus Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Charlottesville and their backers are listed below.
